Partner and Founder of LongTaal and VIARES Academy, Board Member at SanaClis
Speaking at: Use of Electronic Data and Artificial Intelligence in Clinical Research
December 3, 2024 | 16:30 – 18:00
Vladimir has over 30 years of experience in biomedical R&D, with a career that includes roles such as a research scientist at George Washington University School of Medicine, a Fogarty Fellow at the National Cancer Institute (NIH) in Bethesda, Maryland, and several senior positions at Quintiles (IQVIA), including VP and Head of Global Operations Center, Member of the Global Leadership Team, and Regional VP for CEE and MENA. He is the Partner and Founder of LongTaal, a clinical trial informatics company, and the Partner and Co-founder of VIARES Academy, a Vienna-based academy for clinical research. Additionally, Vladimir serves as a non-executive board director at SanaClis, a global specialty CRO, where he was the CEO during 2018-19. He is currently the VP of Global Clinical Trial Strategy at CSOFT Health Sciences, which provides global localization services for health sciences.
He has authored more than 60 research articles and book chapters in peer-reviewed journals. His current research focuses on various aspects of the globalization of industry clinical trials. Vladimir is an editorial board member of the Applied Clinical Research, Clinical Trials and Regulatory Affairs journal and is also a member of the DIA Global Core Committee for Clinical Research and the Core Committee for Diversity, Equity, and Inclusion.
Vladimir holds an MSc degree in solid-state physics from Comenius University and a PhD in biophysics/pharmacology from the Slovak Academy of Sciences.
Selected Recent Bibliography
- Misik V, Bolecek M (2023)
Patient Diversity in Global Industry Clinical Trials: Why It Matters, Who Should Be Concerned, and What Can Be Done?
In: Radenkovic M (eds), Ethics in Scientific Research - New Perspectives, IntechOpen, Rijeka, pp. 1-12.
DOI: 10.5772/intechopen.1001279 - Misik V (2022)
The Impact of the Russia-Ukraine War on Clinical Trials.
Clinical Leader, September 7, 2022. - Misik V (2022)
Assessment of Countries’ Reputation Among Sponsors of Industry Clinical Trials.
Clinical Trial Corner blog, CSOFT Health Sciences, November 3, 2022. - Misik V, Jarosz B, Beckowski L, Czarnecka M, Dabrowski T, Drake D, Milowska K, Ziecik P, Magielski P, Szczepannik W (2021)
REPORT: Industry Clinical Trials in Poland: Possibilities to Increase Number and Scope of Trials in Poland.
Published by INFARMA and POLCRO, December 2021, pp. 1-115. - Misik V, Bolecek M, Brady RV (2017)
Ethical Considerations of Industry-Sponsored Clinical Trials in the Arab Region.
In: Silverman H. (eds), Research Ethics in the Arab Region, Research Ethics Forum, vol. 5, Springer, Cham, pp. 161-170.
